Hey Traders! I’m entering a long on HIPPO/USDT at $0.002255. This pair has recently broken above a short‑term consolidation zone and appears poised for a push. My first target is $0.002795 and, if momentum holds, my second target zone lies between $0.0031200‑$0.003350.
From a technical perspective:
Price is approaching a prior resistance zone (around $0.0028) which, once cleared, could act as new support and open the door toward the $0.0031‑$0.00335 range.
Short‑term momentum is turning positive, with price action showing higher‑lows and a possible breakout of a descending trend‑line.
However, broader technical indicators remain cautious. For example, aggregated oscillator and moving‑average signals for HIPPO show a “Strong Sell” status recently.
This means while the setup has potential, risk is elevated — especially if the breakout fails or broader market turns negative.
As always, use a stop‑loss, manage your risk, and only allocate what you’re comfortable with. Good luck!
From a technical perspective:
Price is approaching a prior resistance zone (around $0.0028) which, once cleared, could act as new support and open the door toward the $0.0031‑$0.00335 range.
Short‑term momentum is turning positive, with price action showing higher‑lows and a possible breakout of a descending trend‑line.
However, broader technical indicators remain cautious. For example, aggregated oscillator and moving‑average signals for HIPPO show a “Strong Sell” status recently.
This means while the setup has potential, risk is elevated — especially if the breakout fails or broader market turns negative.
As always, use a stop‑loss, manage your risk, and only allocate what you’re comfortable with. Good luck!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
